Cargando…

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma

Detalles Bibliográficos
Autores principales:	Henriquez, Soledad, Zerbit, Jérémie, Bruel, Timothée, Ouedrani, Amani, Planas, Delphine, Deschamps, Paul, Staropoli, Isabelle, Hadjadj, Jérôme, Varet, Bruno, Ermak, Natalia, Bouscary, Didier, Willems, Lise, Fouquet, Guillemette, Decroocq, Justine, Franchi, Patricia, Deau-Fischer, Benedicte, Terrier, Benjamin, Tamburini, Jérôme, Chatenoud, Lucienne, Schwartz, Olivier, Vignon, Marguerite
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology. 2022
Materias:	Letters to Blood
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674107/ https://www.ncbi.nlm.nih.gov/pubmed/34905598 http://dx.doi.org/10.1182/blood.2021013714

Ejemplares similares

Immunogénicité du vaccin BNT162b2 chez les patients avec maladies auto-immunes sous immunosuppresseurs
por: Hadjadj, J., et al.
Publicado: (2021)

Management of patients with multiple myeloma in the era of COVID-19 pandemic: how hospital at home changes our medical practice
por: Fouquet, G., et al.
Publicado: (2021)

Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era
por: Zerbit, Jeremie, et al.
Publicado: (2022)

Subcutaneous azacitidine maintenance in transplant-ineligible patients with acute myeloid leukemia: a single-center retrospective study
por: Johnson, Natacha, et al.
Publicado: (2023)

Prognostic Value of FDG-PET/CT Parameters in Patients with Relapse/Refractory Multiple Myeloma before Anti-CD38 Based Therapy
por: Fouquet, Guillemette, et al.
Publicado: (2021)

How to increase first‐time donors' returns? The postdonation letter's content can make a difference
por: Moussaoui, Lisa S., et al.
Publicado: (2022)

Clonal hematopoiesis is not significantly associated with COVID-19 disease severity
por: Zhou, Yifan, et al.
Publicado: (2022)

Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM)
por: Detroit, Marion, et al.
Publicado: (2023)

Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia
por: Chapuis, Nicolas, et al.
Publicado: (2019)

Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis
por: Vazquez, Romain, et al.
Publicado: (2021)

Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein
por: Grignano, E., et al.
Publicado: (2023)

Targeting activated T cells in type I diabetes and islet transplantation
por: Chatenoud, Lucienne
Publicado: (2011)

Therapeutic Targeting of B Cells and T Cells in Autoimmune Diabetes: Is It a Solution?
por: Chatenoud, Lucienne
Publicado: (2013)

Performance characteristics of a novel blood bag in-line closure device and subsequent product quality assessment
por: Serrano, Katherine, et al.
Publicado: (2010)

Failure of self-disclosure of deferrable risk behaviors associated with transfusion-transmissible infections in blood donors
por: Wong, Horas Tze Hoo, et al.
Publicado: (2015)

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone
por: Tedder, Richard S., et al.
Publicado: (2018)

Estimation of the number of blood donors during the COVID‐19 incubation period across China and analysis of prevention and control measures for blood transfusion transmission
por: Yuan, Zhaohu, et al.
Publicado: (2020)

Deferral rate variability in blood donor eligibility assessment
por: de Kort, Wim, et al.
Publicado: (2018)

Ensuring HLA‐matched platelet support requires an ethnic diverse donor population
por: Kreuger, Aukje L., et al.
Publicado: (2020)

First results of a ferritin‐based blood donor deferral policy in the Netherlands
por: Vinkenoog, Marieke, et al.
Publicado: (2020)

Determinants of blood donation willingness in the European Union: a cross‐country perspective on perceived transfusion safety, concerns, and incentives
por: Huis in ‘t Veld, Elisabeth M.J., et al.
Publicado: (2019)

Prediction paradigm involving time series applied to total blood issues data from England
por: Nandi, Anita K., et al.
Publicado: (2020)

Do deferred donors continue their donations? A large‐scale register study on whole blood donor return in the Netherlands
por: Spekman, Marloes L.C., et al.
Publicado: (2019)

Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study
por: Zhao, Jingcheng, et al.
Publicado: (2020)

Whole blood donor behavior and availability after deferral: Consequences of a new ferritin monitoring policy
por: Spekman, Marloes L.C., et al.
Publicado: (2020)

Barriers to blood donation on social media: An analysis of Facebook and Twitter posts
por: Ramondt, Steven, et al.
Publicado: (2020)

Risk of hematological malignancy in blood donors: A nationwide cohort study
por: Zhao, Jingcheng, et al.
Publicado: (2020)

New blood donors in times of crisis: Increased donation willingness, particularly among people at high risk for attracting SARS‐CoV‐2
por: Spekman, Marloes L. C., et al.
Publicado: (2021)

Assessment of serological assays for identifying high titer convalescent plasma
por: Farnsworth, Christopher W., et al.
Publicado: (2021)

Personalized collection of plasma from healthy donors: A randomized controlled trial of a novel technology‐enabled nomogram
por: Hartmann, Jan, et al.
Publicado: (2021)

Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men
por: Castillo, Gisell, et al.
Publicado: (2022)

Sexual risk behavior questions: Understanding and mitigating donor discomfort
por: Haw, Jennie, et al.
Publicado: (2021)

Mitigating the risk of transfusion‐transmitted infections with vector‐borne agents solely by means of pathogen reduction
por: Stramer, Susan L., et al.
Publicado: (2022)

Plasmavigilance—Adverse events among US Source plasma donors
por: Schreiber, George B., et al.
Publicado: (2021)

A robust autonomous method for blood demand forecasting
por: Turkulainen, Esa V., et al.
Publicado: (2022)

What would it take to convince you to donate? A survey study of the relationship between motivators, barriers, and payment for whole blood, plasma, and platelet donation
por: France, Christopher R., et al.
Publicado: (2022)

Predicting vasovagal reactions to a virtual blood donation using facial image analysis
por: Rudokaite, Judita, et al.
Publicado: (2022)

‘Stay at home and limit contact’: The impact of stay‐at‐home advice on the behavior of Australian donors aged 70 and over in the first year of the pandemic
por: Naing, Sanda, et al.
Publicado: (2022)

Blood donation motivators and barriers reported by young, first‐time whole blood donors: Examining the association of reported motivators and barriers with subsequent donation behavior and potential sex, race, and ethnic group differences
por: France, Christopher R., et al.
Publicado: (2022)

The healthy donor effect and survey participation, becoming a donor and donor career
por: Brodersen, Thorsten, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3ed03rolcpar307bkcf7d7t4cu